Oxytetracycline

(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide

C22H24N2O9 (460.1482)


Oxytetracycline is a tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions. [PubChem]Oxytetracycline inhibits cell growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. The binding is reversible in nature. Oxytetracycline is lipophilic and can easily pass through the cell membrane or passively diffuses through porin channels in the bacterial membrane. Oxytetracycline is a clinically used broad-spectrum antibacterial antibiotic. It is approved by FDA for use in fish and animal feeds. Oxytetracycline is known as a broad-spectrum antibiotic due to its activity against such a wide range of infections. It was the second of the tetracyclines to be discovered. Oxytetracycline, like other tetracyclines, is used to treat many infections common and rare. Its better absorption profile makes it preferable to tetracycline for moderately severe acne, but alternatives sould be sought if no improvement occurs by 3 months G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines Clinically used broad-spectrum antibacterial antibiotic. Approved by FDA for use in fish and animal feeds S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Oxytetracycline is an antibiotic belonging to the tetracycline class. Oxytetracycline potent inhibits Gram-negative and Gram-positive bacteria. Oxytetracycline is a protein synthesis inhibitor and prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline also possesses anti-HSV-1 activity[1][2][3].

   

Glucose 6-phosphate

{[(2R,3S,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}phosphonic acid

C6H13O9P (260.0297)


Glucose 6 phosphate (alpha-D-glucose 6 phosphate or G6P) is the alpha-anomer of glucose-6-phosphate. There are two anomers of glucose 6 phosphate, the alpha anomer and the beta anomer. Glucose 6 phosphate is an ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (Stedman, 26th ed). Glucose-6-phosphate is a phosphorylated glucose molecule on carbon 6. When glucose enters a cell, it is immediately phosphorylated to G6P. This is catalyzed with hexokinase enzymes, thus consuming one ATP. A major reason for immediate phosphorylation of the glucose is so that it cannot diffuse out of the cell. The phosphorylation adds a charged group so the G6P cannot easily cross cell membranes. G6P can travel down two metabolic pathways, glycolysis and the pentose phosphate pathway. In addition to the metabolic pathways, G6P can also be stored as glycogen in the liver if blood glucose levels are high. If the body needs energy or carbon skeletons for syntheses, G6P can be isomerized to Fructose-6-phosphate and then phosphorylated to Fructose-1,6-bisphosphate. Note, the molecule now has 2 phosphoryl groups attached. The addition of the 2nd phosphoryl group is an irreversible step, so once this happens G6P will enter glycolysis and be turned into pyruvate (ATP production occurs). If blood glucose levels are high, the body needs a way to store the excess glucose. After being converted to G6P, phosphoglucose mutase (isomerase) can turn the molecule into glucose-1-phosphate. Glucose-1-phosphate can then be combined with uridine triphosphate (UTP) to form UDP-glucose. This reaction is driven by the hydrolysis of pyrophosphate that is released in the reaction. Now, the activated UDP-glucose can add to a growing glycogen molecule with the help of glycogen synthase. This is a very efficient storage mechanism for glucose since it costs the body only 1 ATP to store the 1 glucose molecule and virtually no energy to remove it from storage. It is important to note that glucose-6-phosphate is an allosteric activator of glycogen synthase, which makes sense because when the level of glucose is high the body should store the excess glucose as glycogen. On the other hand, glycogen synthase is inhibited when it is phosphorylated by protein kinase a during times of high stress or low blood glucose levels. -- Wikipedia [HMDB] Glucose 6-phosphate (G6P, sometimes called the Robison ester) is a glucose sugar phosphorylated at the hydroxy group on carbon 6. Glucose 6-phosphate (G6P) has two anomers: the alpha anomer and the beta anomer. Glucose 6-phosphate is an ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose 6-phosphate (Stedman, 26th ed). When glucose enters a cell, it is immediately phosphorylated to G6P. This is catalyzed with hexokinase enzymes, thus consuming one ATP. A major reason for immediate phosphorylation of the glucose is so that it cannot diffuse out of the cell. The phosphorylation adds a charged group so the G6P cannot easily cross cell membranes. G6P can travel down two metabolic pathways: glycolysis and the pentose phosphate pathway. In addition to the metabolic pathways, G6P can also be stored as glycogen in the liver if blood glucose levels are high. If the body needs energy or carbon skeletons for syntheses, G6P can be isomerized to fructose 6-phosphate and then phosphorylated to fructose 1,6-bisphosphate. Note, the molecule now has 2 phosphoryl groups attached. The addition of the 2nd phosphoryl group is an irreversible step, so once this happens G6P will enter glycolysis and be turned into pyruvate (ATP production occurs). If blood glucose levels are high, the body needs a way to store the excess glucose. After being converted to G6P, phosphoglucose mutase (an isomerase) can turn the molecule into glucose 1-phosphate. Glucose 1-phosphate can then be combined with uridine triphosphate (UTP) to form UDP-glucose. This reaction is driven by the hydrolysis of pyrophosphate that is released in the reaction. Now, the activated UDP-glucose can add to a growing glycogen molecule with the help of glycogen synthase. This is a very efficient storage mechanism for glucose since it costs the body only 1 ATP to store the 1 glucose molecule and virtually no energy to remove it from storage. It is important to note that glucose 6-phosphate is an allosteric activator of glycogen synthase, which makes sense because when the level of glucose is high the body should store the excess glucose as glycogen. On the other hand, glycogen synthase is inhibited when it is phosphorylated by protein kinase during times of high stress or low blood glucose levels. Acquisition and generation of the data is financially supported in part by CREST/JST. CONFIDENCE standard compound; INTERNAL_ID 237 KEIO_ID G003; [MS2] KO009109 KEIO_ID G003

   

Tetracycline

(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

C22H24N2O8 (444.1533)


Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic (-)-Tetracycline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=60-54-8 (retrieved 2024-09-27) (CAS RN: 60-54-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Apigenin 7,4'-dimethyl ether

5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one

C17H14O5 (298.0841)


Apigenin 7,4-dimethyl ether, also known as apigenin dimethylether or 4,7-dimethylapigenin, belongs to the class of organic compounds known as 7-O-methylated flavonoids. These are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, apigenin 7,4-dimethyl ether is considered to be a flavonoid lipid molecule. Apigenin 7,4-dimethyl ether is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Outside of the human body, apigenin 7,4-dimethyl ether has been detected, but not quantified in, common sages and sweet basils. This could make apigenin 7,4-dimethyl ether a potential biomarker for the consumption of these foods. BioTransformer predicts that apigenin 7,4-dimethyl ether is a product of 4,5,7-trimethoxyflavone metabolism via an O-dealkylation reaction and catalyzed by CYP2C9 and CYP2C19 enzymes (PMID: 30612223). 4-methylgenkwanin, also known as apigenin dimethylether or 4,7-dimethylapigenin, is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, 4-methylgenkwanin is considered to be a flavonoid lipid molecule. 4-methylgenkwanin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 4-methylgenkwanin can be found in common sage and sweet basil, which makes 4-methylgenkwanin a potential biomarker for the consumption of these food products. The compound 7,4'-Di-O-methylapigenin may be partly responsible for the reported antifungal activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal phytomedicines.And it also showed inhibition of the drug efflux pumps (with IC50 = 51.64 μg/ml). IC50:51.64 μg/ml(Candida albicans drug efflux pumps)[2] In vitro: The isolated 7,4'-Di-O-methylapigenin was further investigated for its inhibitory activity on ABC drug efflux pumps in C. albicans by monitoring an increase in ciprofloxacin, assessing the level of its accumulation, in response to reserpine. There was a higher accumulation of ciprofloxacin in Candida cells in the presence of 7,4'-Di-O-methylapigenin than with reserpine. The compound 7,4'-Di-O-methylapigenine demonstrated the activity in a dose-dependent manner with IC50 value of 51.64 μg/ml. These results support those obtained from synergism assays where by the underlying synergistic antifungal mechanisms could be due to blockage of ABC efflux pumps and increasing the susceptibility of Candida to miconazole.[2] In vivo: In searching for natural products as potential anti-inflammatory agents, 7,4'-Di-O-methylapigenin wasn't evaluated in vivo for its ability to inhibit acute inflammation.[1] The compound 7,4'-Di-O-methylapigenin may be partly responsible for the reported antifungal activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal phytomedicines.And it also showed inhibition of the drug efflux pumps (with IC50 = 51.64 μg/ml). IC50:51.64 μg/ml(Candida albicans drug efflux pumps)[2] In vitro: The isolated 7,4'-Di-O-methylapigenin was further investigated for its inhibitory activity on ABC drug efflux pumps in C. albicans by monitoring an increase in ciprofloxacin, assessing the level of its accumulation, in response to reserpine. There was a higher accumulation of ciprofloxacin in Candida cells in the presence of 7,4'-Di-O-methylapigenin than with reserpine. The compound 7,4'-Di-O-methylapigenine demonstrated the activity in a dose-dependent manner with IC50 value of 51.64 μg/ml. These results support those obtained from synergism assays where by the underlying synergistic antifungal mechanisms could be due to blockage of ABC efflux pumps and increasing the susceptibility of Candida to miconazole.[2] In vivo: In searching for natural products as potential anti-inflammatory agents, 7,4'-Di-O-methylapigenin wasn't evaluated in vivo for its ability to inhibit acute inflammation.[1]

   

Acetoin

1-Hydroxyethyl methyl ketone

C4H8O2 (88.0524)


Acetoin, also known as dimethylketol or 2,3-butanolone, belongs to the class of organic compounds known as acyloins. These are organic compounds containing an alpha hydroxy ketone. Acyloins are formally derived from reductive coupling of carboxylic acyl groups. Thus, acetoin is considered to be an oxygenated hydrocarbon lipid molecule. Acetoin is used as an external energy store by a number of fermentive bacteria. Acetoin, along with diacetyl, is one of the compounds giving butter its characteristic flavor. Acetoin is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. Acetoin is used as a food flavoring (in baked goods) and a fragrance. Acetoin is a sweet, buttery, and creamy tasting compound. Outside of the human body, Acetoin has been detected, but not quantified in several different foods, such as cocoa and cocoa products, evergreen blackberries, orange bell peppers, tortilla chips, and pomes. This could make acetoin a potential biomarker for the consumption of these foods. Constituent of beer, wine, fresh or cooked apple, fresh or cooked leak, corn, honey, cocoa, butter, cheeses, roasted coffee and other foodstuffs. Acetoin, with regard to humans, has been found to be associated with several diseases such as eosinophilic esophagitis and ulcerative colitis; acetoin has also been linked to the inborn metabolic disorder celiac disease. Acetoin is a colorless or pale yellow to green yellow liquid with a pleasant, buttery odor. It can be found in apples, butter, yogurt, asparagus, black currants, blackberry, wheat, broccoli, brussels sprouts, cantaloupe. Constituent of beer, wine, fresh or cooked apple, fresh or cooked leak, corn, honey, cocoa, butter, cheeses, roasted coffee and other foodstuffs. Flavouring ingredient. [DFC]

   

Geosmin

[4S-(4alpha,4aalpha,8abeta)]-Octahydro-4,8a-dimethyl-4a(2H)-naphthalenol

C12H22O (182.1671)


Geosmin is found in corn. Implicated in off-flavour of shellfish, freshwater fish, drinking water and some vegetables.Geosmin, which literally translates to "earth smell", is an organic compound with a distinct earthy flavour and aroma, and is responsible for the earthy taste of beets and a contributor to the strong scent that occurs in the air when rain falls after a dry spell of weather (petrichor) or when soil is disturbed. The human nose is extremely sensitive to geosmin and is able to detect it at concentrations as low as 5 parts per trillion. Implicated in off-flavour of shellfish, freshwater fish, drinking water and some vegetables

   

Guanosine 3',5'-bis(diphosphate)

{[hydroxy({[(2R,3S,4R,5R)-4-hydroxy-2-({[hydroxy(phosphonooxy)phosphoryl]oxy}methyl)-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-3-yl]oxy})phosphoryl]oxy}phosphonic acid

C10H17N5O17P4 (602.957)


Guanosine 3,5-bis(diphosphate) is part of the Purine metabolism pathway. It is a substrate for: Guanosine-3,5-bis(diphosphate) 3-pyrophosphohydrolase MESH1.

   

Adenosine tetraphosphate

{[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}phosphonic acid

C10H17N5O16P4 (586.9621)


Adenosine 5 tetraphosphate, Ap4, is a natural nucleotide present in many biological systems. This nucleotide has been found as a constituent of the nucleotide pool present in the aqueous humor of a number of mammals and appears to act as a regulator of intraocular pressure (PMID: 14600249). AP4 may also play a significant role in the physiological regulation of vascular tone (PMID: 8599250). The plasma concentration of AP4 is in the nanomolar range. Technically adenosine tetraphosphate is condensation product of adenosine with tetraphosphoric acid at the 5 position. Acetyl coenzyme A (CoA) synthetase (EC 6.2.1.1) catalyzes the synthesis of adenosine 5-tetraphosphate (P4A) and adenosine 5-pentaphosphate (p5A) from ATP and tri- or tetrapolyphosphate (P3 or P4). [HMDB] Adenosine 5 tetraphosphate, Ap4, is a natural nucleotide present in many biological systems. This nucleotide has been found as a constituent of the nucleotide pool present in the aqueous humor of a number of mammals and appears to act as a regulator of intraocular pressure (PMID: 14600249). AP4 may also play a significant role in the physiological regulation of vascular tone (PMID: 8599250). The plasma concentration of AP4 is in the nanomolar range. Technically adenosine tetraphosphate is condensation product of adenosine with tetraphosphoric acid at the 5 position. Acetyl coenzyme A (CoA) synthetase (EC 6.2.1.1) catalyzes the synthesis of adenosine 5-tetraphosphate (P4A) and adenosine 5-pentaphosphate (p5A) from ATP and tri- or tetrapolyphosphate (P3 or P4).

   

Guanosine 3'-diphosphate 5'-triphosphate

{[hydroxy({[(2R,3S,4R,5R)-4-hydroxy-2-({[hydroxy({[hydroxy(phosphonooxy)phosphoryl]oxy})phosphoryl]oxy}methyl)-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-3-yl]oxy})phosphoryl]oxy}phosphonic acid

C10H18N5O20P5 (682.9233)


This compound belongs to the family of Purine Ribonucleoside Triphosphates. These are purine ribobucleotides with triphosphate group linked to the ribose moiety.

   

Lipomycin

alpha-Lipomycin

C32H45NO9 (587.3094)


   

Adenosine 5'-pentaphosphate

[({[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C10H18N5O19P5 (666.9284)


Adenosine 5-pentaphosphate is a substrate for: Diphosphoinositol polyphosphate phosphohydrolase 3-alpha, and Diphosphoinositol polyphosphate phosphohydrolase 3-beta.

   

terpentecin

[(2S)-2-{(1R)-1-hydroxy-2-[(1S,2S,3R,4aS,8aS)-3-hydroxy-1,2,4a,5-tetramethyl-4-oxo-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}oxiran-2-yl](oxo)acetaldehyde

C20H28O6 (364.1886)


   

Isobutylhydroxylamine

N-hydroxy-2-methylpropanamine

C4H11NO (89.0841)


A member of the class of hydroxylamines resulting from the replacement of one of the hydrogens attached to the amino group of 2-methylpropanamine by a hydroxy group.

   

Narasin

2H-Pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-

C43H72O11 (764.5074)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents Ionophore effective against viruses and particularly against coccidial infections in chickens Ionophore effective against viruses and particularly against coccidial infections in chicken D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

   

Formycin A

2-{7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C10H13N5O4 (267.0967)


   

Apigenin 7,4'-dimethyl ether

4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-

C17H14O5 (298.0841)


Apigenin 7,4-dimethyl ether, also known as apigenin dimethylether or 4,7-dimethylapigenin, belongs to the class of organic compounds known as 7-O-methylated flavonoids. These are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, apigenin 7,4-dimethyl ether is considered to be a flavonoid lipid molecule. Apigenin 7,4-dimethyl ether is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Outside of the human body, apigenin 7,4-dimethyl ether has been detected, but not quantified in, common sages and sweet basils. This could make apigenin 7,4-dimethyl ether a potential biomarker for the consumption of these foods. BioTransformer predicts that apigenin 7,4-dimethyl ether is a product of 4,5,7-trimethoxyflavone metabolism via an O-dealkylation reaction and catalyzed by CYP2C9 and CYP2C19 enzymes (PMID: 30612223). 4-methylgenkwanin, also known as apigenin dimethylether or 4,7-dimethylapigenin, is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, 4-methylgenkwanin is considered to be a flavonoid lipid molecule. 4-methylgenkwanin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 4-methylgenkwanin can be found in common sage and sweet basil, which makes 4-methylgenkwanin a potential biomarker for the consumption of these food products. Apigenin 7,4-dimethyl ether is a dimethoxyflavone that is the 7,4-dimethyl ether derivative of apigenin. It has a role as a plant metabolite. It is a dimethoxyflavone and a monohydroxyflavone. It is functionally related to an apigenin. Apigenin 7,4-dimethyl ether is a natural product found in Teucrium polium, Calea jamaicensis, and other organisms with data available. A dimethoxyflavone that is the 7,4-dimethyl ether derivative of apigenin. The compound 7,4'-Di-O-methylapigenin may be partly responsible for the reported antifungal activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal phytomedicines.And it also showed inhibition of the drug efflux pumps (with IC50 = 51.64 μg/ml). IC50:51.64 μg/ml(Candida albicans drug efflux pumps)[2] In vitro: The isolated 7,4'-Di-O-methylapigenin was further investigated for its inhibitory activity on ABC drug efflux pumps in C. albicans by monitoring an increase in ciprofloxacin, assessing the level of its accumulation, in response to reserpine. There was a higher accumulation of ciprofloxacin in Candida cells in the presence of 7,4'-Di-O-methylapigenin than with reserpine. The compound 7,4'-Di-O-methylapigenine demonstrated the activity in a dose-dependent manner with IC50 value of 51.64 μg/ml. These results support those obtained from synergism assays where by the underlying synergistic antifungal mechanisms could be due to blockage of ABC efflux pumps and increasing the susceptibility of Candida to miconazole.[2] In vivo: In searching for natural products as potential anti-inflammatory agents, 7,4'-Di-O-methylapigenin wasn't evaluated in vivo for its ability to inhibit acute inflammation.[1] The compound 7,4'-Di-O-methylapigenin may be partly responsible for the reported antifungal activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal phytomedicines.And it also showed inhibition of the drug efflux pumps (with IC50 = 51.64 μg/ml). IC50:51.64 μg/ml(Candida albicans drug efflux pumps)[2] In vitro: The isolated 7,4'-Di-O-methylapigenin was further investigated for its inhibitory activity on ABC drug efflux pumps in C. albicans by monitoring an increase in ciprofloxacin, assessing the level of its accumulation, in response to reserpine. There was a higher accumulation of ciprofloxacin in Candida cells in the presence of 7,4'-Di-O-methylapigenin than with reserpine. The compound 7,4'-Di-O-methylapigenine demonstrated the activity in a dose-dependent manner with IC50 value of 51.64 μg/ml. These results support those obtained from synergism assays where by the underlying synergistic antifungal mechanisms could be due to blockage of ABC efflux pumps and increasing the susceptibility of Candida to miconazole.[2] In vivo: In searching for natural products as potential anti-inflammatory agents, 7,4'-Di-O-methylapigenin wasn't evaluated in vivo for its ability to inhibit acute inflammation.[1]

   

Ekatetrone

Ekatetrone

C19H13NO7 (367.0692)


An organic heterotetracyclic compound that is 1,8-dihydroxy-9,10-anthraquinone which is substituted at position 2 and 3 by 3-amino-1-hydroxy-3-oxopropyl and carboxymethyl groups, respectively, in which the hydroxy group beta- to the carboxamide has undergone formal condensation with the carboxy group to give the corresponding delta-lactone. Isolated from various strains of Kitasatospora aureofaciens (Streptomyces aureofaciens), it inhibits the growth of Ehrlich ascites carcinoma in vitro.

   

5,7,4-Trimethoxy-4-phenylcoumarin

5,7,4-Trimethoxy-4-phenylcoumarin

C18H16O5 (312.0998)


   

Glucose 6-phosphate

D-Glucose 6-phosphate

C6H13O9P (260.0297)


   
   

Olivomycin A

Olivomycin A

C58H84O26 (1196.5251)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D009848 - Olivomycins

   

Venturicidin A

Venturicidin A

C41H67NO11 (749.4714)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents > D014698 - Venturicidins

   

5-Acetyl-5,10-dihydrophenazine-1-carboxylic acid

5-Acetyl-5,10-dihydrophenazine-1-carboxylic acid

C15H12N2O3 (268.0848)


   
   

Oxytetracycline

(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide

C22H24N2O9 (460.1482)


A tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AA - Antibiotics A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic relative retention time with respect to 9-anthracene Carboxylic Acid is 0.486 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.490 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3610 EAWAG_UCHEM_ID 3610; CONFIDENCE standard compound Oxytetracycline is an antibiotic belonging to the tetracycline class. Oxytetracycline potent inhibits Gram-negative and Gram-positive bacteria. Oxytetracycline is a protein synthesis inhibitor and prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline also possesses anti-HSV-1 activity[1][2][3].

   

Tetracycline

2-[amino(hydroxy)methylidene]-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione

C22H24N2O8 (444.1533)


A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

acetoin

3-hydroxybutan-2-one

C4H8O2 (88.0524)


A methyl ketone that is butan-2-one substituted by a hydroxy group at position 3.

   

narasin

narasin

C43H72O11 (764.5074)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

   

adenosine 5'-pentaphosphate

[({[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C10H18N5O19P5 (666.9284)


   

3-Hydroxybutan-2-one

3-Hydroxybutan-2-one

C4H8O2 (88.0524)


   

formycin A

formycin A

C10H13N5O4 (267.0967)


D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D005573 - Formycins

   

6-Chloro-1H-indole-3-carbaldehyde

6-Chloro-1H-indole-3-carbaldehyde

C9H6ClNO (179.0138)


   

Valanimycin

Valanimycin

C7H12N2O3 (172.0848)


An azoxy compound that is acrylic acid in which the olefinic hydrogen at position 2 has been replaced by an isobutyl-ONN-azoxy group.

   

Fuzanin D

Fuzanin D

C13H17NO2 (219.1259)


A diol that is hepta-4,6-diene-2,3-diol substituted by a 3-methylpyridin-2-yl group at position 7 (the 2R,3S,4E,6E stereoisomer). It is isolated from the culture broth of Kitasatospora sp. IFM10917 and exhibits cytotoxicity against human colon carcinoma cells.

   

AIDS-071717

4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)- (9CI)

C17H14O5 (298.0841)


The compound 7,4'-Di-O-methylapigenin may be partly responsible for the reported antifungal activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal phytomedicines.And it also showed inhibition of the drug efflux pumps (with IC50 = 51.64 μg/ml). IC50:51.64 μg/ml(Candida albicans drug efflux pumps)[2] In vitro: The isolated 7,4'-Di-O-methylapigenin was further investigated for its inhibitory activity on ABC drug efflux pumps in C. albicans by monitoring an increase in ciprofloxacin, assessing the level of its accumulation, in response to reserpine. There was a higher accumulation of ciprofloxacin in Candida cells in the presence of 7,4'-Di-O-methylapigenin than with reserpine. The compound 7,4'-Di-O-methylapigenine demonstrated the activity in a dose-dependent manner with IC50 value of 51.64 μg/ml. These results support those obtained from synergism assays where by the underlying synergistic antifungal mechanisms could be due to blockage of ABC efflux pumps and increasing the susceptibility of Candida to miconazole.[2] In vivo: In searching for natural products as potential anti-inflammatory agents, 7,4'-Di-O-methylapigenin wasn't evaluated in vivo for its ability to inhibit acute inflammation.[1] The compound 7,4'-Di-O-methylapigenin may be partly responsible for the reported antifungal activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal phytomedicines.And it also showed inhibition of the drug efflux pumps (with IC50 = 51.64 μg/ml). IC50:51.64 μg/ml(Candida albicans drug efflux pumps)[2] In vitro: The isolated 7,4'-Di-O-methylapigenin was further investigated for its inhibitory activity on ABC drug efflux pumps in C. albicans by monitoring an increase in ciprofloxacin, assessing the level of its accumulation, in response to reserpine. There was a higher accumulation of ciprofloxacin in Candida cells in the presence of 7,4'-Di-O-methylapigenin than with reserpine. The compound 7,4'-Di-O-methylapigenine demonstrated the activity in a dose-dependent manner with IC50 value of 51.64 μg/ml. These results support those obtained from synergism assays where by the underlying synergistic antifungal mechanisms could be due to blockage of ABC efflux pumps and increasing the susceptibility of Candida to miconazole.[2] In vivo: In searching for natural products as potential anti-inflammatory agents, 7,4'-Di-O-methylapigenin wasn't evaluated in vivo for its ability to inhibit acute inflammation.[1]

   

Geosmin

[4S-(4alpha,4aalpha,8abeta)]-Octahydro-4,8a-dimethyl-4a(2H)-naphthalenol

C12H22O (182.1671)


   

Oligomycin D

Oligomycin D

C44H72O11 (776.5074)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D009840 - Oligomycins C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors > D014475 - Uncoupling Agents C254 - Anti-Infective Agent > C258 - Antibiotic

   
   

6-Deoxy-alpha-L-talopyranose

6-Deoxy-alpha-L-talopyranose

C6H12O5 (164.0685)


   

Talosin A

Talosin A

C21H20O9 (416.1107)


A glycosyloxyisoflavone that is genistein attached to a alpha-L-6-deoxy-talopyranosyl residue at position 7 via a glycosidic linkage. Isolated from Kitasatospora kifunensis, it exhibits antifungal activity.

   

Talosin B

Talosin B

C27H30O13 (562.1686)


A glycosyloxyisoflavone that is genistein attached to alpha-L-6-deoxy-talopyranosyl residues at positions 7 and 4 respectively. Isolated from Kitasatospora kifunensis, it exhibits antifungal activity.

   

Adenosine tetraphosphate

Adenosine tetraphosphate

C10H17N5O16P4 (586.9621)


   

GUANOSINE-5,3-tetraphosphATE

GUANOSINE-5,3-tetraphosphATE

C10H17N5O17P4 (602.957)


   

Guanosine pentaphosphate

Guanosine pentaphosphate

C10H18N5O20P5 (682.9233)


   

ADENOSINE-5-pentaphosphATE

ADENOSINE-5-pentaphosphATE

C10H18N5O19P5 (666.9284)


   

anticapsin

anticapsin

C9H13NO4 (199.0845)


An alanine derivative that is L-alanine bearing a 5-oxo-7-oxabicyclo[4.1.0]hept-2-yl substituent at position 3.

   

(4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

(4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

C22H24N2O9 (460.1482)


   

(1r,6r,8as)-6-hydroxy-8-methyl-1-[(1e)-5-oxohex-1-en-1-yl]-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

(1r,6r,8as)-6-hydroxy-8-methyl-1-[(1e)-5-oxohex-1-en-1-yl]-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

C14H19NO4 (265.1314)


   

2-[(1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene)amino]-3-methylbutanoic acid

2-[(1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene)amino]-3-methylbutanoic acid

C17H28N2O6 (356.1947)


   

(16z)-7-acetyl-13-ethyl-16-ethylidene-2,5,8,11,14,20-hexahydroxy-4-[(7-methoxy-1h-indol-3-yl)methyl]-7,18,22-trimethyl-24-thia-3,6,9,12,15,18,21,26-octaazabicyclo[21.2.1]hexacosa-1(25),2,5,8,11,14,20,23(26)-octaen-17-one

(16z)-7-acetyl-13-ethyl-16-ethylidene-2,5,8,11,14,20-hexahydroxy-4-[(7-methoxy-1h-indol-3-yl)methyl]-7,18,22-trimethyl-24-thia-3,6,9,12,15,18,21,26-octaazabicyclo[21.2.1]hexacosa-1(25),2,5,8,11,14,20,23(26)-octaen-17-one

C36H45N9O9S (779.3061)


   

6,8-dihydroxy-3-methyl-1-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetraphene-7,12-dione

6,8-dihydroxy-3-methyl-1-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetraphene-7,12-dione

C25H22O9 (466.1264)


   

9-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]phenazine-1-carboxylic acid

9-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]phenazine-1-carboxylic acid

C18H16N2O3 (308.1161)


   

(6s,9s,14s,17s)-17-ethenyl-6-(hydroxymethyl)-9,14-diisopropyl-10,14,17-trimethyl-2,7,10-triazatetracyclo[9.7.1.0⁴,¹⁹.0¹³,¹⁸]nonadeca-1(18),3,7,11(19),12-pentaen-8-ol

(6s,9s,14s,17s)-17-ethenyl-6-(hydroxymethyl)-9,14-diisopropyl-10,14,17-trimethyl-2,7,10-triazatetracyclo[9.7.1.0⁴,¹⁹.0¹³,¹⁸]nonadeca-1(18),3,7,11(19),12-pentaen-8-ol

C28H41N3O2 (451.3199)


   

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-10-ethyl-1,3,9,27-tetrahydroxy-7,11-dioxo-13-propyl-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-10-ethyl-1,3,9,27-tetrahydroxy-7,11-dioxo-13-propyl-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

C39H61NO14 (767.4092)


   

6-hydroxy-1-(5-hydroxyhex-1-en-1-yl)-8-methyl-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

6-hydroxy-1-(5-hydroxyhex-1-en-1-yl)-8-methyl-1h,5h,6h,8ah-[1,3]oxazolo[3,4-a]pyridin-3-one

C14H21NO4 (267.1471)


   

(4s,4as,11r,11ar,12as)-7-chloro-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-1,12-dioxo-4a,5,11,11a-tetrahydro-4h-tetracene-2-carboximidic acid

(4s,4as,11r,11ar,12as)-7-chloro-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-1,12-dioxo-4a,5,11,11a-tetrahydro-4h-tetracene-2-carboximidic acid

C21H21ClN2O7 (448.1037)


   

(2s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-n-[(2s)-1-(4-hydroxyphenyl)-3-oxopropan-2-yl]-4-methylpentanimidic acid

(2s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-n-[(2s)-1-(4-hydroxyphenyl)-3-oxopropan-2-yl]-4-methylpentanimidic acid

C29H39N3O6 (525.2839)


   

(2s,3s)-3-[(1s,3r,4r)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-2-{[(2s,4r,5r,6r)-4-{[(2s,4r,5s,6r)-4-{[(2s,4s,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-6-{[(2s,4r,5s,6r)-5-hydroxy-4-{[(2r,4r,5s,6s)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-7-methyl-3,4-dihydro-2h-anthracen-1-one

(2s,3s)-3-[(1s,3r,4r)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-2-{[(2s,4r,5r,6r)-4-{[(2s,4r,5s,6r)-4-{[(2s,4s,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-6-{[(2s,4r,5s,6r)-5-hydroxy-4-{[(2r,4r,5s,6s)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-7-methyl-3,4-dihydro-2h-anthracen-1-one

C53H78O24 (1098.4883)


   

9-{3-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]but-1-en-1-yl}phenazine-1-carboxylic acid

9-{3-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]but-1-en-1-yl}phenazine-1-carboxylic acid

C24H26N2O7 (454.174)


   

3-(1-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}ethyl)-4,6,7,10,12-pentamethyl-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

3-(1-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}ethyl)-4,6,7,10,12-pentamethyl-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

C34H56O14 (688.367)


   

5-hydroxy-3-(4-hydroxyphenyl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-4-one

5-hydroxy-3-(4-hydroxyphenyl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-4-one

C21H20O9 (416.1107)


   

(3r,4r,6s,6ar,7s,8ar,10r,12s,12ar,12br)-4,6,7,10,12-pentamethyl-3-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

(3r,4r,6s,6ar,7s,8ar,10r,12s,12ar,12br)-4,6,7,10,12-pentamethyl-3-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

C28H46O9 (526.3142)


   

n-[(2e)-2-[(2e,4e,7e)-undeca-2,4,7-trien-1-ylidene]hydrazin-1-ylidene]hydroxylamine

n-[(2e)-2-[(2e,4e,7e)-undeca-2,4,7-trien-1-ylidene]hydrazin-1-ylidene]hydroxylamine

C11H17N3O (207.1372)


   

3,4,5-trihydroxy-6-methyloxan-2-yl 6-chloro-1h-indole-3-carboxylate

3,4,5-trihydroxy-6-methyloxan-2-yl 6-chloro-1h-indole-3-carboxylate

C15H16ClNO6 (341.0666)


   

(1s,16r,17r,19r)-16-{[(2s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

(1s,16r,17r,19r)-16-{[(2s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)


   

(1r,3r,5r,7s,9s,13r,17s,18r,19z,21z,23e,25e,27e,29e,31e,33r,35s,36r,37s)-33-{[(2s,3r,4r,5r,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-17-[(2r,5r)-7-(4-aminophenyl)-5-hydroxy-7-oxoheptan-2-yl]-1,3,5,7,9,13,37-heptahydroxy-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid

(1r,3r,5r,7s,9s,13r,17s,18r,19z,21z,23e,25e,27e,29e,31e,33r,35s,36r,37s)-33-{[(2s,3r,4r,5r,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-17-[(2r,5r)-7-(4-aminophenyl)-5-hydroxy-7-oxoheptan-2-yl]-1,3,5,7,9,13,37-heptahydroxy-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid

C58H84N2O19 (1112.5668)


   

(16r,17r,19r)-16-{[4,5-dihydroxy-5-(1-hydroxyethyl)-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

(16r,17r,19r)-16-{[4,5-dihydroxy-5-(1-hydroxyethyl)-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H34N2O10 (618.2213)


   

3-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-2-{[4-({4-[(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-6-({5-hydroxy-4-[(4-hydroxy-5-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-7-methyl-3,4-dihydro-2h-anthracen-1-one

3-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-2-{[4-({4-[(4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-5-hydroxy-6-methyloxan-2-yl]oxy}-8,9-dihydroxy-6-({5-hydroxy-4-[(4-hydroxy-5-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-7-methyl-3,4-dihydro-2h-anthracen-1-one

C53H78O24 (1098.4883)


   

2-hydroxy-n-[6-hydroxy-13-isopropyl-2,10,10,16-tetramethyl-8-(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

2-hydroxy-n-[6-hydroxy-13-isopropyl-2,10,10,16-tetramethyl-8-(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C36H51N3O13 (733.3422)


   

(2s,4r)-n-{2-chloro-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid

(2s,4r)-n-{2-chloro-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid

C18H33ClN2O5S (424.1799)


   

(6s,9s,14r,17r)-17-ethenyl-6-(hydroxymethyl)-9,14-diisopropyl-10,14,17-trimethyl-2,7,10-triazatetracyclo[9.7.1.0⁴,¹⁹.0¹³,¹⁸]nonadeca-1(18),3,7,11(19),12-pentaen-8-ol

(6s,9s,14r,17r)-17-ethenyl-6-(hydroxymethyl)-9,14-diisopropyl-10,14,17-trimethyl-2,7,10-triazatetracyclo[9.7.1.0⁴,¹⁹.0¹³,¹⁸]nonadeca-1(18),3,7,11(19),12-pentaen-8-ol

C28H41N3O2 (451.3199)


   

5,7-dimethoxy-4-phenylchromen-2-one

5,7-dimethoxy-4-phenylchromen-2-one

C17H14O4 (282.0892)


   

1-[3-(hydroxymethyl)-9h-pyrido[3,4-b]indol-1-yl]ethane-1,2-diol

1-[3-(hydroxymethyl)-9h-pyrido[3,4-b]indol-1-yl]ethane-1,2-diol

C14H14N2O3 (258.1004)


   

(4s,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,11,12a-pentahydroxy-1,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid

(4s,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,11,12a-pentahydroxy-1,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid

C21H21ClN2O8 (464.0986)


   

Chlorotetracycline

Chlorotetracycline

C22H23ClN2O8 (478.1143)


-

   

(6r)-6-{[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxochromen-7-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylic acid

(6r)-6-{[2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4-oxochromen-7-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylic acid

C21H16O12 (460.0642)


   

(2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6s)-6-[(2s,5s,7r,9s,10s,12r,15r)-2-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5⁷.3⁵]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid

(2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6s)-6-[(2s,5s,7r,9s,10s,12r,15r)-2-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5⁷.3⁵]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid

C43H72O11 (764.5074)


   

3-[(6s,9s,12s,15s,18s,19r)-15-benzyl-18-{[(3-heptyloxiran-2-yl)(hydroxy)methylidene]amino}-5,8,11,14,17-pentahydroxy-9-[(5-hydroxy-1h-indol-3-yl)methyl]-6-(4-hydroxyphenyl)-19-methyl-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-12-yl]propanoic acid

3-[(6s,9s,12s,15s,18s,19r)-15-benzyl-18-{[(3-heptyloxiran-2-yl)(hydroxy)methylidene]amino}-5,8,11,14,17-pentahydroxy-9-[(5-hydroxy-1h-indol-3-yl)methyl]-6-(4-hydroxyphenyl)-19-methyl-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-12-yl]propanoic acid

C49H59N7O13 (953.4171)


   

(16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

(16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)


   

n-[(2z)-2-[(2e,4e,6e,8e)-undeca-2,4,6,8-tetraen-1-ylidene]hydrazin-1-ylidene]hydroxylamine

n-[(2z)-2-[(2e,4e,6e,8e)-undeca-2,4,6,8-tetraen-1-ylidene]hydrazin-1-ylidene]hydroxylamine

C11H15N3O (205.1215)


   

2-[(2e,5e,7e,9r,10r,11e)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraen-1-yl]-5,6-dimethoxy-3-methylpyridin-4-ol

2-[(2e,5e,7e,9r,10r,11e)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraen-1-yl]-5,6-dimethoxy-3-methylpyridin-4-ol

C25H37NO4 (415.2722)


   

(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene]amino}-3-methylbutanoic acid

(2s)-2-{[(2s)-1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene]amino}-3-methylbutanoic acid

C17H28N2O6 (356.1947)


   

6,8-dihydroxy-3-methyl-1-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}tetraphene-7,12-dione

6,8-dihydroxy-3-methyl-1-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}tetraphene-7,12-dione

C25H22O9 (466.1264)


   

[hydroxy([hydroxy([hydroxy(phosphonooxy)phosphoryl]oxy)phosphoryl]oxy)phosphoryl]oxyphosphonic acid; ribonucleoside

[hydroxy([hydroxy([hydroxy(phosphonooxy)phosphoryl]oxy)phosphoryl]oxy)phosphoryl]oxyphosphonic acid; ribonucleoside

C10H20N5O21P5 (700.9339)


   

n-{2-hydroxy-1-[3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid

n-{2-hydroxy-1-[3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid

C18H34N2O6S (406.2137)


   

(2e,4s,5s,6e,8e)-10-[(2r,3s,6s,8r,9s)-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

(2e,4s,5s,6e,8e)-10-[(2r,3s,6s,8r,9s)-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C29H42O7 (502.293)


   

(1s,16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

(1s,16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)


   

5-(2-hydroxyacetyl)-10h-phenazine-1-carboxylic acid

5-(2-hydroxyacetyl)-10h-phenazine-1-carboxylic acid

C15H12N2O4 (284.0797)


   

13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-23-(dimethylamino)-11,15,22,24-tetrahydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7,9(14),15-hexaene-6,17-dione

13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-23-(dimethylamino)-11,15,22,24-tetrahydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7,9(14),15-hexaene-6,17-dione

C36H45NO14 (715.284)


   

(2z,4s,4as,5as,6s,12as)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4h-tetracene-1,3,12-trione

(2z,4s,4as,5as,6s,12as)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-4a,5,5a,6-tetrahydro-4h-tetracene-1,3,12-trione

C21H21ClN2O8 (464.0986)


   

3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyldodeca-4,6,8,10-tetraenimidic acid

3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyldodeca-4,6,8,10-tetraenimidic acid

C18H23NO4 (317.1627)


   

[hydroxy([hydroxy([hydroxy(phosphonooxy)phosphoryl]oxy)phosphoryl]oxy)phosphoryl]oxyphosphonic acid; adenosine

[hydroxy([hydroxy([hydroxy(phosphonooxy)phosphoryl]oxy)phosphoryl]oxy)phosphoryl]oxyphosphonic acid; adenosine

C10H20N5O20P5 (684.939)


   

(3-amino-3-{[(1s)-1-{[(1s)-1-carboxy-3-methylbutyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propyl)(hydroxymethyl)oxo-λ⁵-phosphanylium

(3-amino-3-{[(1s)-1-{[(1s)-1-carboxy-3-methylbutyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propyl)(hydroxymethyl)oxo-λ⁵-phosphanylium

[C14H27N3O6P]+ (364.1637)


   

2-[(1r)-10,12-dihydroxy-3,6,11-trioxo-1,4-dihydro-2-oxatetracen-1-yl]ethanimidic acid

2-[(1r)-10,12-dihydroxy-3,6,11-trioxo-1,4-dihydro-2-oxatetracen-1-yl]ethanimidic acid

C19H13NO7 (367.0692)


   

(2e,4e,6e,10e,12r,13r,14r,15s,16e,18e,20e,22e,24e,26e,29s,30r,33r,35s,36e,39s,41s,43r,44e,47s,49r,50e,53s,55r)-58-carbamimidamido-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

(2e,4e,6e,10e,12r,13r,14r,15s,16e,18e,20e,22e,24e,26e,29s,30r,33r,35s,36e,39s,41s,43r,44e,47s,49r,50e,53s,55r)-58-carbamimidamido-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

C63H99N3O18S (1217.6644)


   

2-hydroxy-n-[(2s,5s,8s,13s,16r,17s)-6-hydroxy-2,10,10,16-tetramethyl-8,13-bis(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

2-hydroxy-n-[(2s,5s,8s,13s,16r,17s)-6-hydroxy-2,10,10,16-tetramethyl-8,13-bis(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C37H53N3O13 (747.3578)


   

(2e)-4-{[(2r,4r,5s,6s)-2-hydroxy-2-[(2s,3r,4s)-3-hydroxy-4-[(2r,3s,4e,6e,9s,10s,11r,12e,14z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-5-methyloxan-4-yl]oxy}-4-oxobut-2-enimidic acid

(2e)-4-{[(2r,4r,5s,6s)-2-hydroxy-2-[(2s,3r,4s)-3-hydroxy-4-[(2r,3s,4e,6e,9s,10s,11r,12e,14z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-5-methyloxan-4-yl]oxy}-4-oxobut-2-enimidic acid

C39H61NO11 (719.4244)


   

(2e)-4-{[(2r,4r,5s,6r)-2-hydroxy-2-[(2s,3r,4s)-3-hydroxy-4-[(2r,3s,4z,6z,9s,10s,11r,12z,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-5-methyloxan-4-yl]oxy}-4-oxobut-2-enimidic acid

(2e)-4-{[(2r,4r,5s,6r)-2-hydroxy-2-[(2s,3r,4s)-3-hydroxy-4-[(2r,3s,4z,6z,9s,10s,11r,12z,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-5-methyloxan-4-yl]oxy}-4-oxobut-2-enimidic acid

C39H61NO11 (719.4244)


   

(1s,5s,8s,10r)-10-isopropyl-4,8-dimethyl-9-oxatricyclo[6.2.1.0¹,⁵]undecane

(1s,5s,8s,10r)-10-isopropyl-4,8-dimethyl-9-oxatricyclo[6.2.1.0¹,⁵]undecane

C15H26O (222.1984)


   

9-(3-methyl-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}but-1-en-1-yl)phenazine-1-carboxylic acid

9-(3-methyl-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}but-1-en-1-yl)phenazine-1-carboxylic acid

C24H26N2O7 (454.174)


   

n-[(2e)-2-[(2e,4e,6e,8e)-undeca-2,4,6,8-tetraen-1-ylidene]hydrazin-1-ylidene]hydroxylamine

n-[(2e)-2-[(2e,4e,6e,8e)-undeca-2,4,6,8-tetraen-1-ylidene]hydrazin-1-ylidene]hydroxylamine

C11H15N3O (205.1215)


   

22-ethyl-7,11,15-trihydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,29-octamethyl-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-oxane]-4,18,20-triene-3,9,13-trione

22-ethyl-7,11,15-trihydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,29-octamethyl-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-oxane]-4,18,20-triene-3,9,13-trione

C44H72O10 (760.5125)


   

n-[(2e)-2-[(2e,4e)-undeca-2,4-dien-1-ylidene]hydrazin-1-ylidene]hydroxylamine

n-[(2e)-2-[(2e,4e)-undeca-2,4-dien-1-ylidene]hydrazin-1-ylidene]hydroxylamine

C11H19N3O (209.1528)


   

(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1-carboxylate

(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1-carboxylate

C19H18N2O6 (370.1165)


   

(2s)-2-amino-3-[(1r,2r,6r)-5-oxo-7-oxabicyclo[4.1.0]heptan-2-yl]propanoic acid

(2s)-2-amino-3-[(1r,2r,6r)-5-oxo-7-oxabicyclo[4.1.0]heptan-2-yl]propanoic acid

C9H13NO4 (199.0845)


   

3-(15-benzyl-18-{[(3-heptyloxiran-2-yl)(hydroxy)methylidene]amino}-5,8,11,14,17-pentahydroxy-9-[(5-hydroxy-1h-indol-3-yl)methyl]-6-(4-hydroxyphenyl)-19-methyl-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-12-yl)propanoic acid

3-(15-benzyl-18-{[(3-heptyloxiran-2-yl)(hydroxy)methylidene]amino}-5,8,11,14,17-pentahydroxy-9-[(5-hydroxy-1h-indol-3-yl)methyl]-6-(4-hydroxyphenyl)-19-methyl-2-oxo-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-12-yl)propanoic acid

C49H59N7O13 (953.4171)


   

(4s,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

(4s,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboximidic acid

C22H23ClN2O8 (478.1143)


   

(2r,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl 9-(4-hydroxy-3-methylbut-2-en-1-yl)phenazine-1-carboxylate

(2r,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl 9-(4-hydroxy-3-methylbut-2-en-1-yl)phenazine-1-carboxylate

C25H28N2O7 (468.1896)


   

(2e,4e,6e,10e,13r,14r,15s,16e,18e,20e,22e,24e,26e,33r,35s,36e,39s,41s,43r,44e,47s,49r,50e,53s,55r)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

(2e,4e,6e,10e,13r,14r,15s,16e,18e,20e,22e,24e,26e,33r,35s,36e,39s,41s,43r,44e,47s,49r,50e,53s,55r)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

C62H97NO15 (1095.6858)


   

(6s,9s,14r,17s)-17-ethenyl-6-(hydroxymethyl)-9,14-diisopropyl-10,14,17-trimethyl-2,7,10-triazatetracyclo[9.7.1.0⁴,¹⁹.0¹³,¹⁸]nonadeca-1(18),3,7,11(19),12-pentaen-8-ol

(6s,9s,14r,17s)-17-ethenyl-6-(hydroxymethyl)-9,14-diisopropyl-10,14,17-trimethyl-2,7,10-triazatetracyclo[9.7.1.0⁴,¹⁹.0¹³,¹⁸]nonadeca-1(18),3,7,11(19),12-pentaen-8-ol

C28H41N3O2 (451.3199)


   

(2s,3s)-2-{[(2s)-1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene]amino}-3-methylpentanoic acid

(2s,3s)-2-{[(2s)-1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene]amino}-3-methylpentanoic acid

C18H30N2O6 (370.2104)


   

(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 6-chloro-1h-indole-3-carboxylate

(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 6-chloro-1h-indole-3-carboxylate

C15H16ClNO6 (341.0666)


   

(3r,4r,6s,6ar,7s,8ar,10r,12s,12ar,12br)-3-(1-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}ethyl)-4,6,7,10,12-pentamethyl-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

(3r,4r,6s,6ar,7s,8ar,10r,12s,12ar,12br)-3-(1-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}ethyl)-4,6,7,10,12-pentamethyl-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

C34H56O14 (688.367)


   

(2s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-n-[(2r)-1-(4-hydroxyphenyl)-3-oxopropan-2-yl]-3-methylbutanimidic acid

(2s)-2-{[(2s)-1-hydroxy-2-[(1-hydroxy-3-methylbutylidene)amino]-3-(4-hydroxyphenyl)propylidene]amino}-n-[(2r)-1-(4-hydroxyphenyl)-3-oxopropan-2-yl]-3-methylbutanimidic acid

C28H37N3O6 (511.2682)


   

3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1-carboxylate

3,4,5-trihydroxy-6-methyloxan-2-yl phenazine-1-carboxylate

C19H18N2O6 (370.1165)


   

(10s,13s)-5-[(3r)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-5-[(3r)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C27H39N3O2 (437.3042)


   

(2e,6e,8e)-10-{8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl}-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

(2e,6e,8e)-10-{8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl}-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C29H42O7 (502.293)


   

[hydroxy([(2r,3s,4r,5r)-4-hydroxy-3-{[hydroxy(phosphonooxy)phosphoryl]oxy}-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy)phosphoryl]oxyphosphonic acid

[hydroxy([(2r,3s,4r,5r)-4-hydroxy-3-{[hydroxy(phosphonooxy)phosphoryl]oxy}-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy)phosphoryl]oxyphosphonic acid

C10H17N5O17P4 (602.957)


   

22-ethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,29-octamethyl-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-oxane]-4,18,20-triene-3,9,13-trione

22-ethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,29-octamethyl-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-oxane]-4,18,20-triene-3,9,13-trione

C44H72O11 (776.5074)


   

(1s,3r,5r,7r,9s,13r,17r,18s,19z,21z,23e,25e,27e,29e,31e,33s,35r,36r,37r)-33-{[(2r,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,7,9,13,37-heptahydroxy-17-[(2r,5r)-5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid

(1s,3r,5r,7r,9s,13r,17r,18s,19z,21z,23e,25e,27e,29e,31e,33s,35r,36r,37r)-33-{[(2r,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,7,9,13,37-heptahydroxy-17-[(2r,5r)-5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid

C59H86N2O19 (1126.5824)


   

(4e,6e,8e,10e)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyldodeca-4,6,8,10-tetraenimidic acid

(4e,6e,8e,10e)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-8-methyldodeca-4,6,8,10-tetraenimidic acid

C18H23NO4 (317.1627)


   

4,6,7,10,12-pentamethyl-3-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

4,6,7,10,12-pentamethyl-3-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-dodecahydro-3h-naphtho[1,2-c]oxocine-1,8-dione

C28H46O9 (526.3142)


   

3-amino-n-[(2r,5r,8s,13s,16r,17s)-5-[(2r)-butan-2-yl]-6-hydroxy-2,10,10,16-tetramethyl-8,13-bis(2-methylpropyl)-3,9,11,14,18-pentaoxo-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-2-hydroxybenzenecarboximidic acid

3-amino-n-[(2r,5r,8s,13s,16r,17s)-5-[(2r)-butan-2-yl]-6-hydroxy-2,10,10,16-tetramethyl-8,13-bis(2-methylpropyl)-3,9,11,14,18-pentaoxo-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-2-hydroxybenzenecarboximidic acid

C36H53N3O12 (719.3629)


   

(3r,4s,5r)-2-{7-amino-2h-pyrazolo[4,3-d]pyrimidin-3-yl}-5-(hydroxymethyl)oxolane-3,4-diol

(3r,4s,5r)-2-{7-amino-2h-pyrazolo[4,3-d]pyrimidin-3-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C10H13N5O4 (267.0967)


   

3-amino-2-hydroxy-n-[6-hydroxy-2,10,10,16-tetramethyl-8,13-bis(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]benzenecarboximidic acid

3-amino-2-hydroxy-n-[6-hydroxy-2,10,10,16-tetramethyl-8,13-bis(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]benzenecarboximidic acid

C36H53N3O12 (719.3629)


   

2-[(1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene)amino]-3-methylpentanoic acid

2-[(1-hydroxy-2-{[hydroxy(3-isopropyl-4-oxooxetan-2-yl)methylidene]amino}-3-methylbutylidene)amino]-3-methylpentanoic acid

C18H30N2O6 (370.2104)


   

(1s,11r,12r,13r,21s,22s,23s,24s)-13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-24-({5-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-4,6-dimethyl-4-nitrooxan-2-yl}oxy)-23-(dimethylamino)-11,15,22-trihydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7(16),8,14-hexaene-6,17-dione

(1s,11r,12r,13r,21s,22s,23s,24s)-13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-24-({5-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-4,6-dimethyl-4-nitrooxan-2-yl}oxy)-23-(dimethylamino)-11,15,22-trihydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7(16),8,14-hexaene-6,17-dione

C51H70N2O22 (1062.442)


   

[(2e,4e,6e,10e,16e,18e,20e,22e,24e,26e,36e,44e,50e)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-1-methoxy-2,12,14,30-tetramethyl-1,31-dioxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaen-29-yl]oxysulfonic acid

[(2e,4e,6e,10e,16e,18e,20e,22e,24e,26e,36e,44e,50e)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-1-methoxy-2,12,14,30-tetramethyl-1,31-dioxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaen-29-yl]oxysulfonic acid

C63H99NO18S (1189.6583)


   

[hydroxy([hydroxy([(2r,3s,4r,5r)-4-hydroxy-3-{[hydroxy(phosphonooxy)phosphoryl]oxy}-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphoryl]oxyphosphonic acid

[hydroxy([hydroxy([(2r,3s,4r,5r)-4-hydroxy-3-{[hydroxy(phosphonooxy)phosphoryl]oxy}-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy)phosphoryl]oxy)phosphoryl]oxyphosphonic acid

C10H18N5O20P5 (682.9233)


   

(1r,11s,12s,13r,21r,22s,23s,24s)-13-{[(2s,3r,4r,5s,6s)-4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl]oxy}-24-{[(2s,4s,5s,6r)-5-{[(2s,3r,4r,5s,6s)-4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl]oxy}-4,6-dimethyl-4-nitrooxan-2-yl]oxy}-23-(dimethylamino)-11,15,22-trihydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-3,7(16),9(14),18-tetraene-6,17-dione

(1r,11s,12s,13r,21r,22s,23s,24s)-13-{[(2s,3r,4r,5s,6s)-4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl]oxy}-24-{[(2s,4s,5s,6r)-5-{[(2s,3r,4r,5s,6s)-4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl]oxy}-4,6-dimethyl-4-nitrooxan-2-yl]oxy}-23-(dimethylamino)-11,15,22-trihydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-3,7(16),9(14),18-tetraene-6,17-dione

C51H74N2O22 (1066.4733)


   

(2r,3r,4r,6s)-6-{[(2r,3s,4r,6r)-6-{[(2r,3s,4r,6r)-6-{[(2r,3s)-3-[(1s,3r,4r)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-8,9-dihydroxy-6-{[(2r,4r,5r,6r)-5-hydroxy-4-{[(2s,4r,5r,6r)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-7-methyl-1-oxo-3,4-dihydro-2h-anthracen-2-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl acetate

(2r,3r,4r,6s)-6-{[(2r,3s,4r,6r)-6-{[(2r,3s,4r,6r)-6-{[(2r,3s)-3-[(1s,3r,4r)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-8,9-dihydroxy-6-{[(2r,4r,5r,6r)-5-hydroxy-4-{[(2s,4r,5r,6r)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-7-methyl-1-oxo-3,4-dihydro-2h-anthracen-2-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl acetate

C55H80O25 (1140.4988)


   

(2e,4e,6e,10e,16e,18e,20e,22e,24e,26e,36e,44e,50e)-58-carbamimidamido-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

(2e,4e,6e,10e,16e,18e,20e,22e,24e,26e,36e,44e,50e)-58-carbamimidamido-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

C63H99N3O18S (1217.6644)


   

5-(4-hydroxy-3-methylbut-2-en-1-yl)-9-(3-methylbut-2-en-1-yl)-7-oxophenazine-1-carboxylic acid

5-(4-hydroxy-3-methylbut-2-en-1-yl)-9-(3-methylbut-2-en-1-yl)-7-oxophenazine-1-carboxylic acid

C23H24N2O4 (392.1736)


   

(10s,13s)-5-[(3s)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

(10s,13s)-5-[(3s)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol

C27H39N3O2 (437.3042)


   

(2e,4e,6e,10e,12s,13r,14r,15r,16e,18e,20e,22e,24e,26e,30r,33s,35s,36e,39s,41r,43r,44e,47s,49s,50e,53s,55r)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

(2e,4e,6e,10e,12s,13r,14r,15r,16e,18e,20e,22e,24e,26e,30r,33s,35s,36e,39s,41r,43r,44e,47s,49s,50e,53s,55r)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid

C62H97NO14 (1079.6909)


   

(2e)-n-[(3s,6s,15r,18s,21s,24r,27r,28r)-18-benzyl-21-[(2r)-butan-2-yl]-5,8,11,14,17,23,26-heptahydroxy-24-(c-hydroxycarbonimidoylmethyl)-6,15-diisopropyl-19,28-dimethyl-3-(2-methylpropyl)-2,20-dioxo-1-oxa-4,7,10,13,16,19,22,25-octaazacyclooctacosa-4,7,10,13,16,22,25-heptaen-27-yl]-3-{2-[(1e)-prop-1-en-1-yl]phenyl}prop-2-enimidic acid

(2e)-n-[(3s,6s,15r,18s,21s,24r,27r,28r)-18-benzyl-21-[(2r)-butan-2-yl]-5,8,11,14,17,23,26-heptahydroxy-24-(c-hydroxycarbonimidoylmethyl)-6,15-diisopropyl-19,28-dimethyl-3-(2-methylpropyl)-2,20-dioxo-1-oxa-4,7,10,13,16,19,22,25-octaazacyclooctacosa-4,7,10,13,16,22,25-heptaen-27-yl]-3-{2-[(1e)-prop-1-en-1-yl]phenyl}prop-2-enimidic acid

C56H80N10O12 (1084.5957)


   

8-hydroxy-3-methyl-1,6-bis({[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})tetraphene-7,12-dione

8-hydroxy-3-methyl-1,6-bis({[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})tetraphene-7,12-dione

C31H32O13 (612.1843)


   

n-[(2z)-2-[(2e,4e)-undeca-2,4-dien-1-ylidene]hydrazin-1-ylidene]hydroxylamine

n-[(2z)-2-[(2e,4e)-undeca-2,4-dien-1-ylidene]hydrazin-1-ylidene]hydroxylamine

C11H19N3O (209.1528)


   

(1s,11r,12r,13r,21s,22s,23r,24s)-13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-23-(dimethylamino)-11,15,22,24-tetrahydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7,9(14),15-hexaene-6,17-dione

(1s,11r,12r,13r,21s,22s,23r,24s)-13-[(4,5-dihydroxy-3-methoxy-4,6-dimethyloxan-2-yl)oxy]-23-(dimethylamino)-11,15,22,24-tetrahydroxy-12-methoxy-1,11-dimethyl-20,25-dioxahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁹,¹⁴]pentacosa-2(19),3,5(18),7,9(14),15-hexaene-6,17-dione

C36H45NO14 (715.284)


   

2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(2s,5s,7r,10s,12r,15r)-2-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5⁷.3⁵]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid

2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(2s,5s,7r,10s,12r,15r)-2-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5⁷.3⁵]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid

C43H72O11 (764.5074)